Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 1.57475
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

29.81 -0.52 (-1.71%)

26.16% Fall from 52W High

864.1K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Capricor Therapeutics Inc is on 22 May 2026 for the purpose of Capricor Therapeutics Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

4.5 / 100

Technically Neutral

58.5 / 100

1Yr Price target upside is 80%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

26.16% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart